![Donna McLaren](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Donna McLaren
Keine laufenden Positionen mehr
Karriereverlauf von Donna McLaren
Ehemalige bekannte Positionen von Donna McLaren
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
StemCells, Inc.
![]() StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Corporate Officer/Principal | 23.09.2009 | - |
Ausbildung von Donna McLaren
University of Cincinnati (Ohio) | Graduate Degree |
Statistik
International
Vereinigte Staaten | 3 |
Operativ
Corporate Officer/Principal | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
StemCells, Inc.
![]() StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
- Börse
- Insiders
- Donna McLaren
- Erfahrung